A miR‐194/PTBP1/CCND3 axis regulates tumor growth in human hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A miR‐194/PTBP1/CCND3 axis regulates tumor growth in human hepatocellular carcinoma

Published:2019-08-27 Issue:3 Volume:249 Page:395-408
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Kang Hoin¹²,Heo Sungeun³,Shin Jung Jae³,Ji Eunbyul¹,Tak Hyosun¹,Ahn Sojin¹,Lee Kyung Jin⁴,Lee Eun Kyung¹²,Kim Wook³^ORCID

Affiliation:

1. Department of BiochemistryThe Catholic University of Korea, College of Medicine Seoul South Korea

2. Institute of Aging and Metabolic DiseasesThe Catholic University of Korea, College of Medicine Seoul South Korea

3. Department of Molecular Science and TechnologyAjou University Suwon South Korea

4. Department of Convergence Medicine, Asan Institute for Life SciencesUniversity of Ulsan College of Medicine Seoul South Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5325

Reference49 articles.

1. Development of Molecularly Targeted Therapies in Hepatocellular Carcinoma: Where Do We Go Now?

2. Management of HCC

3. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

4. Hepatocellular carcinoma: clinical frontiers and perspectives

5. Hepatocellular carcinoma

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCL7A inhibits the progression and drug-resistance in acute myeloid leukemia;Drug Resistance Updates;2024-09

2. Circ-MEG3 inhibits the malignant proliferation of human cervical cancer cells;2024-03-08

3. Circ-CCT2 Activates Wnt/β-catenin Signaling to Facilitate Hepatoblastoma Development by Stabilizing PTBP1 mRNA;Cellular and Molecular Gastroenterology and Hepatology;2024

4. PTBP1 as a potential regulator of disease;Molecular and Cellular Biochemistry;2023-12-22

5. Polypyrimidine Tract Binding Protein: A Universal Player in Cancer Development;Current Molecular Medicine;2023-10-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3